SEC Form 4/A · accession 0000899243-17-005883
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Anastasios Gianakakos
Officer — President and CEO · Director
Period of report
Apr 29, 2016
Accepted (ET)
Mar 1, 2017 · 9:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Apr 29, 2016 | A | 2,279 | $8.50 | A | 484,444 | D | |
| Common Stock | holding | — | — | — | 204,081 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4/A is being filed solely to correct the transaction code in the original Form 4 filing.
- F2Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan.